Market Access for Pharmaceutical Products – trends and challenges

Marlene Gyldmark
Head of Modelling, Outcomes Research, Statistics and Epidemiology

Assessment group, Global Pricing and
Market Access
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
CH-4070 Basel

Telephone: +41 61 688 94 86

Marlene Gyldmark joined Roche Global Headquarter in the Global Pricing and Market Access group November 2000. 

Current job responsibility at Roche is as Head of Modelling, Outcomes Research, Statistics and Epidemiology (MORSE) – HTA group, within Global Pricing and Market Access. The MORSE group is responsible for payer and HTA evidence generation.

Previous work experience include e.g. Health Economic Manager at Pfizer Denmark; International Health Economic and Strategic Pricing Manager Novo Nordisk International, Denmark; lecturer in economics at Royal Danish University of Pharmacy, Copenhagen, Denmark; Research Scientist at DSI - Institute for Health Service Research and Development, where Marlene participated in a number of EU concerted action projects on e.g. willingness to pay, economics of intensive care, socio-economic costs of AIDS and the HARMET project on standardizing methods for economic evaluation. Additional work experience includes Health Economist in the Tanzanian Ministry of Health, Dar es Salaam, Tanzania. 

Marlene holds an MA in Economics, University of Copenhagen, Denmark, and an MPhil in Health Economics, University of York, UK.